Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab influence on thiopurine metabolism in Crohn's disease
NL-OMON24966Recruiting
- Start
- Jan 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of adalimumab in Crohn's disease, sponsored by none. Started Jan 2008; status: recruiting.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON24966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24966.